Acta Oncologica · 1997 · 10 citations · 15 references
MedicineOncologySurgeryChemotherapyGynecologic OncologyMetastasisCancer StagingCombination ChemotherapyFallopian Tube CancerMalignant NeoplasmsMalignant TumorsOvarian CancerIsolated MetastasesMalignant Ovarian NeoplasmsOptimal Treatment RegimesOvarian Cancer MetastasisOvarian Cancer RadiotherapyPrimary Ovarian CarcinomaRadiation Therapy CombinationsSplenic Metastasis
Adenocarcinoma of the fallopian tube is the rarest gynecologic malignancy (1) accounting for 0.30 to 1.11% (2) of all gynecologic cancers. Because of the clinical and histological similarity between tubal and epithelial ovarian cancer, most patients are staged and treated in an identical manner with cytoreductive surgery and adjuvant cisplatin chemotherapy with or without radiotherapy (3, 4). Several authors (2, 3, 5) illustrate the possible value of PAC combination chemotherapy. Although the natural history of the disease has been described in recent reviews (5, 6), the optimal treatment is unknown. The case reported in this article gives an account of the natural history of a primary adenocarcinoma of the fallopian tube with an isolated splenic metastasis treated by surgery, radiation therapy and chemothrapy.
15
Leon Morgenstern, James L. Rosenberg, Stephen A. Geller · World Journal of Surgery · 1985 · 127 citations
Carcinoma of the fallopian tube: Management and sites of failure
Earlene H. McMurray, Allan J. Jacobs, Carlos A. Perez et al. · Cancer · 1986 · 96 citations · Full text
Medicine, Gynecology, Surgery +17
Primary carcinoma of the fallopian tube
Karl C. Podratz, Edward Podczaski, Thomas A. Gaffey et al. · American Journal of Obstetrics and Gynecology · 1986 · 94 citations